CONTINUE TO SITE
OR WAIT null SECS
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
Dr. Ramasamy discusses investigational oral testosterone treatment
Ranjith Ramasamy, MD, comments on SOV2012-F1 (Kyzatrex), an oral testosterone undecanoate soft gelatin capsule.
In this video, Ranjith Ramasamy, MD, discusses SOV2012-F1 (Kyzatrex), an oral testosterone undecanoate soft gelatin capsule for which the FDA recently accepted a new drug application. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
